Found 6 matching trials
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin PHASE3 Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Show More Location
Investigational Site Number 392028
Learn More & Join Trial
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC PHASE2 Study to determine the effect of the investigational drug bezafibrate (BZF)...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis PHASE3 Up to 40% of patients with PBC have an inadequate response to standard trea...
Show More Location
Instituto Mexicano de Seguro Social
Learn More & Join Trial
Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis PHASE3 Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease that...
Show More Location
Hepatology department - Hopital Saint Antoine
Learn More & Join Trial
Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders PHASE3 The primary biliary cholangitis (PBC), formerly known as primary biliary ci...
Show More Location
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Learn More & Join Trial
Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC PHASE2 Study to evaluate the efficacy, safety, and tolerability of investigational...
Show More Location
Flinders Medical Centre
Learn More & Join Trial